SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wexler LH, Crist WM, Hilman LJ. Rhabdomyosarcoma and the undifferentiated sarcomas. In: PizzoPA, PoplackDG, editors. Principles and practices of pediatric oncology. Philadelphia: Lippincott Williams & Wilkins, 2001: 939971.
  • 2
    Gurney JG, Young JL, Roffers SD, Smith MA, Bunin GR. Soft tissue sarcomas. In: RiesLAG, SmithMA, GurneyJG, et al., editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, 1999: 111124. Available from URL: http://www.seer.cancer.gov [accessed July 22, 2004].
  • 3
    Bleyer WA. Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol. 2002; 38: 110.
  • 4
    Bleyer WA, Tejeda H, Murphy SB, et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health. 1997; 21: 366373.
  • 5
    Ross JA, Severson RK, Pollock BH, Robison LL. Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer. 1996; 77: 201207.
  • 6
    Shochat SJ, Fremgen AM, Murphy SB, et al. Childhood cancer: patterns of protocol participation in a national survey. CA Cancer J Clin. 2001; 51: 119130.
  • 7
    Bernstein L, Sullivan-Halley J, Krailo MD, Hammond GD. Trends in patterns of treatment of childhood cancer in Los Angeles County. Cancer. 1993; 71: 32223228.
  • 8
    Krailo MD, Bernstein L, Sullivan-Halley J, Hammond GD. Patterns of enrollment on cooperative group studies. An analysis of trends from the Los Angeles County Cancer Surveillance Program. Cancer. 1993; 71: 33253330.
  • 9
    Kadan-Lottick NS, Ness KK, Bhatia S, Gurney JG. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA. 2003; 290: 20082014.
  • 10
    Pui CH, Sandlund JT, Pei D, et al. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA. 2003; 290: 20012007.
  • 11
    National Cancer Institute. Surveillance, Epidemiology and End Results [website]. Available from URL: http://www.seer.cancer.gov/about/ [accessed July 22, 2004].
  • 12
    National Cancer Institute. Surveillance, Epidemiology and End Results [website]. Available from URL: http://www.seer.cancer.gov/quality.html [accessed July 22, 2004].
  • 13
    National Cancer Institute. SEER cancer incidence public-use database, 1973–2000. November 2002 submission [CD ROM]. April 2003. Available from URL: http://www.seer.cancer.gov/publicdata/documentation/html [accessed July 22, 2004].
  • 14
    Percy C, Van Holten V, Muir C. International classification of diseases for oncology. 2nd edition. Geneva: World Health Organization, 1990.
  • 15
    Kramarova E, Stiller CA. The international classification of childhood cancer. Int J Cancer. 1996; 68: 759765.
  • 16
    Lawless JF. Life tables, graphs, and related procedures. In: LawlessJF. Statistical models and methods for lifetime data. New York: John Wiley & Sons, 1982: 5281.
  • 17
    Rodary C, Gehan EA, Flamant F, et al. Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop. Med Pediatr Oncol. 1991; 19: 8995.
  • 18
    Raney RB, Anderson JR, Barr FG, et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol. 2001; 23: 215220.
  • 19
    Henson DE, Ries LA. On the estimation of survival. Semin Surg Oncol. 1994; 10: 26.
  • 20
    Myers MH, Ries LA. Cancer patient survival rates: SEER program results for 10 years of follow-up. CA Cancer J Clin. 1989; 39: 2132.
  • 21
    Berrino F, Micheli A, Sant M, Capocaccia R. Interpreting survival differences and trends. Tumori. 1997; 83: 916.
  • 22
    Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons, 1980.
  • 23
    Cox DR. Regression models and life tables. J R Stat Soc [B]. 1972; 34: 187220.
  • 24
    Cantor AB. Proportional hazards regression. In: CantorAB. SAS survival analysis techniques for medical research. 2nd edition. Cary, NC: SAS Institute, Inc., 2003: 136138.
  • 25
    Joshi D, Anderson JR, Paidas C, Breneman J, Parham DM, Crist W. Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer 2004; 42: 6473.
  • 26
    Stiller CA, Stevens MC, Magnani C, Corazziari I, Group EW. Survival of children with soft-tissue sarcoma in Europe since 1978: results from the EUROCARE study. Eur J Cancer. 2001; 37: 767774.
  • 27
    Michelagnoli MP, Pritchard J, Phillips MB. Adolescent oncology-a homeland for the “lost tribe.” Eur J Cancer. 2003; 39: 25712572.
  • 28
    Baker KS, Anderson JR, Lobe TE, et al. Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol. 2002; 20: 44284433.
  • 29
    Sung L, Anderson JR, Donaldson SS, Spunt SL, Crist WM, Pappo AS. Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Eur J Cancer 2004; 40: 18781885.
  • 30
    Berrino F, Esteve J, Coleman MP. Basic issues in estimating and comparing survival of cancer patients. In: BerrinoF, SantM, VerdecchiaA, CapocacciaR, HakulinenT, EsteveJ, editors. Survival of cancer patients in Europe. IARC Scientific Pub. No. 132. Lyon, France: IARC Scientific Publications, 1995: 113.
  • 31
    RiesLAG, EisnerMP, KosaryCL, et al., editors. SEER Cancer Statistics Review, 1975–2001, National Cancer Institute. Bethesda, 2004. Available from URL: http://www.seer.cancer.gov/csr/1975_2001/ [accessed July 22, 2004].
  • 32
    Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985; 312: 16041608.
  • 33
    Pappo AS. Rhabdomyosarcoma and other soft tissue sarcomas of childhood. Curr Opin Oncol. 1995; 7: 361366.
  • 34
    Ruymann FB, Grufferman S. Introduction and epidemiology of soft tissue sarcomas. In: MaurerHM, RuymannFB, PochedlyC, editors. Rhabdomyosarcoma and related tumors in children and adolescents. Boca Raton, FL: CRC Press, Inc., 1991: 318.
  • 35
    Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001; 19: 31633172.